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background: Based on a presumed negative impact of overweight and obesity on reproductive capacity and pregnancy outcome,
some national guidelines and clinicians have argued that there should be an upper limit for a woman’s BMI to access assisted reproductive
technologies (ART). However, evidence on the risk of complications or expected success rate of ART in obese women is scarce. We there-
fore performed a systematic review on the subject.
methods: We searched the literature for studies reporting on complications or success rates in overweight and obese women under-
going ART. Articles were scored on methodological quality. We calculated pooled odds ratios (ORs) to express the association between
overweight and obesity on the one hand, and complications and success rates of ART on the other hand. We only pooled results if data
were available per woman instead of per cycle or embryo transfer.
results: We detected 14 studies that reported on the association between overweight and complications during or after ART, of which
6 reported on ovarian hyperstimulation syndrome (OHSS), 7 on multiple pregnancies and 6 on ectopic pregnancies. None of the individual
studies found a positive association between overweight and ART complications. The pooled ORs for overweight versus normal weight for
OHSS, multiple pregnancy and ectopic pregnancy were 1.0 [95% conﬁdence interval (CI) 0.77–1.3], 0.97 (95% CI 0.91–1.04) and 0.96 (95%
CI 0.54–1.7), respectively. In 27 studies that reported on BMI and the success of ART, the pooled ORs for overweight versus normal weight
on live birth, ongoing and clinical pregnancy following ART were OR 0.90 (95% CI 0.82–1.0), 1.01 (95% CI 0.75–1.4) and OR 0.94 (95% CI
0.69–1.3), respectively.
conclusions: Data on complications following ART are scarce and therefore a registration system should be implemented in order to
gain more insight into this subject. In the available literature, there is no evidence of overweight or obesity increasing the risk of complications
following ART. Furthermore, they only marginally reduce the success rates. Based on the currently available data, overweight and obesity in
itself should not be a reason to withhold ART.
Key words: assisted reproduction / body mass / ectopic pregnancy / OHSS / multiple pregnancy
Introduction
Obesity is a growing problem throughout the Western world with
more than half of the women in the UK and USA being overweight
or obese, and up to 25% of women in their reproductive age being
obese (Haslam and James, 2005; Balen and Anderson, 2007).
Several studies have shown that obesity is associated with a
reduced fecundity (Jensen et al., 1999; Ramlau-Hansen et al.,
2007; Van der Steeg et al., 2007). In addition, obese women are
more prone to anovulation (Pasquali et al., 2007) and symptoms
of polycystic ovarian syndrome (PCOS) are aggravated by obesity.
Pregnancy in overweight and obese women is associated with an
increased risk of complications, leading to higher maternal and neo-
natal morbidity and mortality and increased costs (Sebire et al.,
2001; Cedergren, 2004; Linne´, 2004; Weiss et al., 2004; Usha
Kiran et al., 2005).
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Due to the worldwide epidemic of obesity, an increasing proportion
of women seeking medical help for subfertility will be overweight or
obese. In their analysis, Vahratian and Smith (2009) found that, in com-
parison to normal weight women, obese women seek medical atten-
tion for their subfertility more often. They receive, however, the least
fertility-related services. Guidelines that regulate access to fertility care
for overweight and obese women vary worldwide. In New Zealand,
for example, women with a BMI of .32 kg/m2 are excluded from
any fertility treatment. Almost all clinics in the UK have an upper
BMI limit for access to assisted reproductive technologies (ART),
ranging from 25 to 40 kg/m2 (Gillett et al., 2006; Zachariah et al.,
2006; Awartani et al., 2009). The UK national guideline recommends
that women with a BMI above 29 kg/m2 should be informed about
their lower pregnancy chances but does not explicitly prescribe a
BMI cut-off point for treatment (NICE, 2004).
Recently, the ESHRE Task Force on Ethics and Law (2010),
reported on lifestyle-related factors, i.e. alcohol consumption,
smoking and obesity, and access to medically assisted reproduction.
It was argued that if a high risk of serious harm for the future child
is anticipated, fertility treatment should be denied. Although this risk
is obvious for alcohol consumption and smoking, it is unclear
whether this recommendation can be applied in daily clinical practice
with respect to adipose subfertile women.
Data regarding the impact of overweight and obesity on fertility
treatment outcome are conﬂicting, with some studies showing a nega-
tive impact on pregnancy rates, whereas others report no impact
(Fedorcsak et al., 2004; Balen et al., 2006; Dokras et al., 2006). In a
systematic review of the literature on overweight and ART, Mahesh-
wari et al. (2007) concluded that there is insufﬁcient evidence of the
effect of BMI on the outcome of ART to justify denial of treatment
for overweight and obese women.
Apart from the impact of overweight and obesity on spontaneous
pregnancy rates and the course of pregnancy, little is known about
the impact of BMI on complications of ART. Some have suggested
that women with a high BMI are more prone to complications
during their fertility treatment and fertility treatment should therefore
be denied.
The aim of the present systematic review was to investigate the as-
sociation between overweight or obesity and the occurrence of com-
plications of ART, as well as the expected outcome in terms of clinical
and ongoing pregnancy and live birth rates. To do so, we updated the
review of Maheshwari et al. (2007), and added a new review with data
on the impact of overweight and obesity on the risk of complications
of ART.
Materials and Methods
We searched the literature from January 1999 till July 2011 for studies that
reported on the association between overweight and obesity on complica-
tions of ART, as well as for studies that reported on the association
between overweight and obesity and the effectiveness of ART. We
searched PubMed, Embase, DARE and the Cochrane Library for studies
reporting on the association between BMI and complications of ART.
Only studies in English were included. To do so, we combined the key-
words (‘obesity’, ‘overweight’ or ‘body mass index’), (‘complication’,
‘ovarian hyperstimulation syndrome’, ‘ectopic pregnancy’, ‘multiple preg-
nancy’, ‘infection’, ‘haemorrhage’ or ‘injury’) and (‘in vitro fertilisation’).
In the search for studies on the association between overweight and
obesity and the outcome of ART, we added the keywords (‘outcome’,
‘pregnancy rate’, ‘live birth rate’). Additionally, we checked the references
of the selected articles for relevant articles.
Since overweight and obese women are more prone to PCOS, which
has an increased risk of ovarian hyperstimulation syndrome (OHSS)
after ART (Tummon et al., 2005), we searched and described this
group separately using keywords mentioned above in combination with
(‘polycystic ovarian syndrome’).
Study quality
Two reviewers independently screened titles and abstracts of all retrieved
studies (A.M.H.K. and M.A.Q.M.). We obtained full-text reports of
studies that were likely to evaluate the association between BMI and com-
plications or BMI and success rates of ART. If the title did not contain any
of our keywords, it was excluded. Reviews were excluded. If not enough
data were available for a 2 × 2 table, studies were excluded. Studies
reporting on fertility treatment other than IVF/ICSI were excluded.
Studies that did not report sufﬁcient data for a 2 × 2 table, but for
which data could possibly be obtained from the authors, were also
evaluated.
We extracted data on study characteristics, study quality and 2 × 2
tables of test accuracy using a predesigned data extraction form. In the
case of multiple publications on the same data set, we used all publications
to acquire complete data. The most recent and complete results were
included in the analysis. If data on test accuracy or on other relevant char-
acteristics were missing, we contacted the corresponding author. Dis-
agreement on data was resolved by discussion and consensus. If
consensus could not be reached, a third reviewer (B.W.M.) was consulted.
Methodological quality of selected papers was evaluated using
QUADAS, a tool for quality assessment of studies of diagnostic accuracy
(Whiting et al., 2003). We adjusted the original QUADAS list in order to
evaluate items that we considered of speciﬁc importance for this system-
atic review. Included studies were evaluated on 15 items concerning
patient selection, veriﬁcation, description of the tests and of the study
population. A comprehensive list of items on which the methodological
study quality was assessed is available from the authors on request.
We deﬁned complications of ART as OHSS, multiple pregnancy, ectopic
pregnancy, haemorrhage, infection or injury to pelvic structures. We
deﬁned success rates of ART as clinical pregnancy rate, ongoing pregnancy
rate, live birth rate and delivery rate.
If data on live birth rates were available, we used these data to calculate
odds ratios (ORs) with 95% conﬁdence intervals (CIs). If live birth rates
were not available, we used pregnancy rates (clinical or ongoing preg-
nancy) for the calculations. Some studies report outcome per cycle,
with several cycles per woman included. This would suggest better
results in terms of pregnancy rates. Therefore, we report outcome (per
ﬁrst cycle) per woman where possible. In order to obtain clinically
useful outcome, we chose to only pool data if results per woman were
available.
Data synthesis
From each article, we calculated the OR from a 2 × 2 table cross-
classifying BMI and one of the aforementioned outcomes. We used the
WHO deﬁnitions for overweight (BMI . 25 kg/m2) and obesity (BMI .
30 kg/m2), where possible. Data of each outcome were pooled if the
data were analysed per woman and if there were at least two studies
with similar deﬁnition of the outcome and similar range of BMI for the
comparison groups. Combined ORs and 95% CI were calculated using
the Review Manager (RevMan 5.1) computer software of the Cochrane
Collaboration. The heterogeneity was assessed with the I2-statistic for
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inconsistency. A value of .50% was considered as substantial heterogen-
eity (Higgins et al., 2003). In the case of statistical homogeneity, we used a
ﬁxed-effect model. In the case of substantial heterogeneity, we used the
random-effect model instead of the ﬁxed-effect model.
Results
Our literature search resulted in 91 studies on the association
between BMI and complications of ART and 242 studies on the asso-
ciation between BMI and the effectiveness of ART, respectively. The
separate search on the association between overweight women
with PCOS and complications after ART or the effectiveness of
ART yielded a total of 77 articles in total.
Based on titles and abstracts derived from the search on studies
between BMI and complications, 24 articles were identiﬁed as poten-
tially eligible for the review (Fig. 1).
Eleven studies were excluded because they were solely concerned
with women with PCOS and another 8 because they lacked adequate
data; however, another 9 studies were identiﬁed by cross-referencing
making 14 available for analysis.
Table I shows the characteristics of the 14 studies and the results
per woman if available, otherwise per cycle for each complication.
Only 2 out of the 14 studies were prospective. It was unclear
whether a BMI threshold was used for access to ART. None of the
researchers reported blinding for BMI status in the assessment of end-
points. Of the 14 studies, 6 reported on the relationship between
OHSS and BMI, 7 reported on the relationship between multiple preg-
nancies and BMI and 6 reported on the relationship between ectopic
pregnancies and BMI. We found no studies that reported on the com-
plications infection, haemorrhage or injury to pelvic structures in rela-
tion to BMI in women undergoing ART. Three out of the 14 studies
used a different deﬁnition than the WHO deﬁnition for overweight
(Table I legend).
None of the six studies that reported on OHSS found a signiﬁcant
difference between the risk of OHSS in normal and overweight
women. The pooled OR for overweight woman was 1.0 (95% CI
0.77–1.3) (Fig. 2).
Of the seven studies that reported on the relation between BMI and
multiple pregnancies for women undergoing ART, the retrospective
cohort study of Spandorfer et al. (2004) found a signiﬁcantly higher
risk of multiple pregnancies in women with normal weight following
ART, whereas six other studies did not. The pooled OR expressing
the association between overweight and the risk of multiple pregnan-
cies was 0.97 (95% CI 0.91–1.04) (Fig. 3).
Six studies reported on the association between BMI and ectopic
pregnancies. None of these studies revealed a signiﬁcant difference
between normal and overweight women. The pooled OR expressing
the association between overweight and the risk of ectopic pregnancy
was 0.96 (95% CI 0.54–1.7) (Fig. 4).
After screening of titles and abstracts derived from the search on
242 studies reporting on the association between BMI and the effect-
iveness of ART, 39 articles were identiﬁed as potentially eligible for the
review. After exclusion of papers that studied only patients with PCOS
and those with insufﬁcient data, 25 papers remained and a further 2
were identiﬁed by cross-referencing yielding 27 suitable for analysis
(Fig. 5).
Of the 27 included studies, 4 were prospective (Table II). Eleven
studies reported on live birth rates, 2 on delivery rates, whereas 14
studies reported on pregnancy rates. The deﬁnition of delivery rate
given in Dokras et al. (2006) is delivery after 20 weeks of gestation,
whereas no deﬁnition is provided in Wittemer et al. (2000). Nine
studies reported on clinical pregnancy rate, four on ongoing pregnancy
rate and one reported on fecundity. Deﬁnitions of these outcome
measures differed between studies. Six out of the 27 studies used a
different deﬁnition for overweight and obesity than the WHO deﬁn-
ition (Table II legend).
In 4 of the 27 included studies, a signiﬁcant negative effect of an
increased BMI on outcome was found, 22 studies did not ﬁnd a signiﬁ-
cant association between BMI and ART outcome, and 1 study
reported signiﬁcantly more pregnancies in obese women. In 17
studies, results were presented per woman, and in 10 studies,
results were presented per cycle or per embryo transfer (ET). There-
fore, not all study results were comparable, and as a result, only seven
studies could be pooled for the live birth rate per woman, our primary
interest.
Overweight women undergoing ART had a signiﬁcant lower live
birth rate after ART than women with a normal weight [OR 0.90
(95% CI 0.82–1.0)] (Fig. 6), whereas obesity did not show a statistic-
ally signiﬁcant difference in six studies including almost 10 000 women
[OR 0.89 (95% CI 0.76–1.03)]. Clinical pregnancy rates were not dif-
ferent for overweight and normal weight women [OR 0.94 (95% CI
Figure 1 Flowchart in/exclusion studies for complications in
ART. (a) Beydoun et al. (2009), Esinler et al. (2005), Fedorcsa´k
et al. (2001), Kolibianakis et al. (2003), Kumbak and Kahraman
(2009), Kurzawa et al. (2008), Li et al. (2010), Liberty et al.
(2010), Lu et al. (2005), Salobir et al. (2002), Yarali et al.
(2004). (b) Aramwit et al. (2008), Brannian et al. (2001), la
Cour Freiesleben et al. (2011), Dechaud et al. (2006), Jacobsen
et al. (2008), Jayaprakasan et al. (2009), Lee et al. (2008), Tur
et al. (2001). (c) Dokras et al. (2006), Fedorcsak et al. (2004),
Luke et al. (2011), Maheshwari (2009a), Matalliotakis et al.
(2008), Sathya et al. (2010), Spandorfer et al. (2004), Van
Swieten et al. (2005), Zhang et al. (2010).
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Table I Incidence of complications following ART in overweighta versus normal weight women.
Study ART n Per Complication rate in overweighta versus normal weight women
OHSS Multiple pregnancy Ectopic pregnancy
Incidence % OR (95% CI) Incidence % (p/p) OR (95% CI) Incidence % (p/p) OR (95% CI)
BMI > 25 BMI < 25 BMI > 25 BMI < 25 BMI > 25 BMI < 25
Luke et al. (2011) IVF 451 63 ET NA NA NA 32 32 1.0 (0.9 to 1.1) NA NA NA
Farhi et al. (2010) IVF 233 Woman 2.7 3.8 0.7 (0.1 to 3.7) NA NA NA NA NA NA
Sathya et al. (2010) IVF 308 Woman NA NA NA 32 26 1.3 (0.6 to 3.1) 6.7 2.6 2.7 (0.3 to 22.7)
Zhang et al. (2010) IVF/ICSI 2628 Woman NA NA NA NA NA NA 4.5 3.8 1.2 (0.5 to 2.9)
Maheshwari et al. (2009a) IVF 1756 Woman 10.3 10.2 1.0 (0.7 to 1.4) 18 21 0.9 (0.6 to 1.3) NA NA NA
Sneed et al. (2008) IVF/ICSI 1273 Woman NA NA NA NA NA NA 1.7 3.0 0.6 (0.2 to 1.8)
Matalliotakis et al. (2008) IVF/ICSI 278 Woman NA NA NA 28b 27b 1.1 (0.5 to 2.1)b 1.1b 1.2b 1.0 (0.06 to 15.5)b
Esinler et al. (2008) ICSI 775 ET 0.8 1.0 0.9 (0.2 to 3.0) 47 52 0.8 (0.6 to 1.2) NA NA NA
Dokras et al. (2006) IVF/ICSI 1291 Woman 4.8 4.8 1.0 (0.6 to 1.6) 28 31 0.9 (0.6 to 1.2) NA NA NA
Van Swieten et al. (2005)c IVF/ICSI 162 Woman 4.9 5.0 1.0 (0.2 to 4.3) NA NA NA NA NA NA
Spandorfer et al. (2004) IVF/ICSI 828 Cycle NA NA NA 36d 52d 0.5 (0.3 to 0.8)d NA NA NA
Fedorcsak et al. (2004) IVF/ICSI 2660 Woman NA NA NA NA NA NA 0.5 1.7 0.3 (0.03 to 2.0)
Wittemer et al. (2000) IVF/ICSI 325 Cycle NA NA NA NA NA NA 15.0 5.0 3.4 (0.6 to 18.2)
Lashen et al. (1999)c IVF 228 Woman 2.6e 5.3e 0.5 (0.1 to 2.4) NA NA NA NA NA NA
OHSS, ovarian hyperstimulation syndrome; p/p, per pregnancy; NA, not available.
aComparisons as stated except where indicated bBMI . 24, dBMI . 27, eBMI . 28 versus BMI 20–25.
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0.69–1.3)] or for obese women when compared with normal weight
women [OR 0.97 (95% CI 0.59–1.6)]. For ongoing pregnancy rates,
the pooled ORs were 1.01 (95% CI 0.75–1.4) and 0.96 (95% CI
0.64–1.4) for overweight and obesity, respectively (data not shown).
Our search retrieved 77 studies on the association between over-
weight women with PCOS and the effectiveness of ART. Two
studies report on complications in PCOS women with respect to
their BMI. Ozgun et al. (2011) report on multiple pregnancy rate,
showing no difference between BMI, 30 versus .30 kg/m2 (P ¼1).
Liberty et al. (2010) describe women with haemorrhage after
oocyte retrieval, in which they conclude that lean women with
PCOS (BMI 19–21 kg/m2) are at more risk of this complication
(4.5 versus 0%) than obese women with PCOS.
Four studies reported on BMI and outcome in PCOS women
(Table III). All studies showed better outcome for normal weight
women, with an extreme OR 0.2 (95% CI 0.01–1.9) for live birth
rates for overweight woman in McCormick et al. (2008).
Discussion
In this systematic review, we assessed the association between over-
weight and obesity on the one hand and complications and success
Figure 2 OHSS for overweight and normal weight women.
Figure 3 Multiple pregnancies for overweight and normal weight women.
Figure 4 Ectopic pregnancies for overweight and normal weight women.
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rates of ART on the other hand. We summarized the current evidence
on complications following ART with respect to BMI. We found no
impact of overweight or obesity on OHSS, multiple pregnancies or
ectopic pregnancies. A slight negative effect on live birth rate is
found in overweight and obese women. Literature speciﬁcally report-
ing on the effect of BMI on the aforementioned complications in
women with PCOS was lacking.
One of the drawbacks of our review is the lack of publications on
complications following ART in general. The articles we found did
not study complications of ART in relation to BMI as their primary
outcome; as a consequence, not one was powered to show a signiﬁ-
cant difference. Also with exception of two studies, all were retro-
spective with the possible selection bias and confounding effect. As
our research has been based on this limited and of moderate quality
data, the outcome of our study should be put in this perspective.
Serious complications like infection, haemorrhage, thromboembolism
or even mortality are not documented in relation to BMI. The Safety
Interest Group (SIG) Safety and Quality of the ESHRE recommended
registering mortality following ART worldwide because of this lack of
information. Following this review of the literature, we underscore the
importance of achieving better data collection of morbidity following
ART.
Furthermore, we were not able to differentiate further between
obesity classes because of lacking data. As mentioned earlier,
several clinics throughout the world use upper limits for BMI for
ART with scarce evidence on morbid obese women as a conse-
quence. One might expect more complications or lower outcome
results in obesity class III than in class I (WHO deﬁnition obesity
class I BMI 30–35 kg/m2 and class III BMI. 40 kg/m2) (Luke
et al., 2011). However, in view of the lack of evidence on the out-
comes of ART in severe obesity and in view of the little impact
that we found from mild obesity, it remains difﬁcult to deﬁne a
threshold.
We found an OR of 0.90 for the association between overweight
and life birth, indicating a 10% reduction in the success rates of IVF
in overweight women. The absolute effect of such an association ob-
viously depends on the absolute live birth rates after IVF. When, for
example, the probability of live birth is 30% in a normal weight
woman, then the success rates of an overweight woman drop to
27.8%. In other words, when we treat 46 normal weight women
with IVF, there is one additional pregnancy when compared with
when we treat 46 overweight women with the same treatment.
Another drawback is that most articles are retrospective observa-
tional cohort studies with the disadvantage of observation bias and
confounding. This bias could be overcome with prospective studies
where covariate data can be collected extensively and in sufﬁcient
detail to more accurately evaluate confounding and effect modiﬁca-
tion. Moreover, the studies applied different cut-off points to deﬁne
overweight and obesity, as well as different deﬁnitions of outcome
and the population of women differed between studies. Because of
these differences, we were not able to pool all studies in our analysis,
e.g. half of the studies on live birth rate with 60 000 women could
not be used in our analysis (Wittemer et al., 2000; Lintsen et al.,
2005; Thum et al., 2007; Matalliotakis et al., 2008; Bellver et al.,
2010; Luke et al., 2011) hypothetically changing our conclusion. For
argument sake, we therefore performed the analysis including the
results of Luke et al., comprising 45 000 ET, to establish the possible
impact on our pooled OR. The OR for live birth rate remained
within the same margins with OR 0.86 (CI 0.83–0.9) for overweight
and OR 0.85 (CI 0.81–0.9) for obese women, now also showing a sig-
niﬁcant lower live birth rate for obese women.
We expected to ﬁnd a difference in complication rates in controlled
ovarian hyperstimulation due to difﬁculty monitoring follicles with
ultrasound in overweight or obese women. Therefore, we searched
literature speciﬁcally for this association but we did not identify any
study reporting on this subject. As OHSS is found more often in
women with PCOS (Tummon et al., 2005), we presumed that there
might be a difference between normal and overweight women.
However, no literature was found on the subject.
Our results on the effectiveness of ART concur with those of
Maheshwari et al. (2007). Since publication of that review, 14 relevant
additional studies were published on the subject. We found a moder-
ate negative effect of obesity on ART outcome. Women with a BMI of
25 kg/m2 or higher achieve reasonable, but slightly lower live birth
rates when compared with normal weight women. The fact that the
pooled OR for overweight women is signiﬁcant, but the pooled OR
of obese women lacks statistical signiﬁcance is probably due to the
smaller group of obese women when compared with overweight
women, as point estimates for both groups were from the same mag-
nitude. A large study on subfertile women undergoing ART with au-
tologous and donor oocytes subclassifying between several obesity
classes did show signiﬁcant lower live birth rates in increasing
obesity classes with autologous oocytes (Luke et al., 2011).
However, they compared obesity classes to normal weight women,
whereas we tried to ﬁnd a cut-off value and compare, for example,
BMI. 30 kg/m2 with BMI, 30 kg/m2.
Figure 5 Flowchart in/exclusion studies for outcome ART. (a)
Beydoun et al. (2009), McCormick et al. (2008), Eijkemans et al.
(2005), Jungheim et al. (2009), Kolibianakis et al. (2003), Li et al.
(2010), Liberty et al. (2010), Mulders et al. (2003), Orvieto
et al. (2009b), Ozgun et al. (2011), Pagidas et al. (2010). (b).
Fadini et al. (2009), Kilic et al. (2009), Kumbak et al. (2010),
Kupka et al. (2011). (c). Hill et al. (2011), Sathya et al. (2010).
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Table II Incidence of positive outcomes after ART in overweight and obese versus normal weight women in the studies analysed.
Author Design ART n Outcome Per Incidence of outcome in overweighta versus normal weight women
% women OR (95% CI) % women OR (95% CI)
BMI > 25 BMI < 25 BMI > 30 BMI < 30
Luke et al. (2011) Cohort IVF 451 63 Live birth ET 34 38 0.9 (0.8 to 0.9) 32 36 0.9 (0.8 to 0.9)
Hill et al. (2011)b Cohort IVF 117 Live birth Woman 44 33 1.6 (0.8 to 3.4) 33 40 0.8 (0.3 to 2.1)
Sathya et al. (2010) Cohort IVF 308 cp Woman 41 43 0.9 (0.6 to 1.5) 33 44 0.6 (0.4 to 1.1)
Farhi et al. (2010) Cohort IVF 233 Live birth Woman 41 38 1.1 (0.6 to 2.0) NA NA NA
Kilic et al. (2010) C-S IVF 1970 cp Woman 47 45 1.1 (0.9 to 1.3) 50 44 1.3 (1.1 to 1.5)
Zhang et al. (2010) Cohort IVF/ICSI 2628 Live birth Woman 24 26 0.9 (0.7 to 1.1) 26 26 1.0 (0.4 to 2.4)
Bellver et al. (2010) Cohort IVF/ICSI 6500 Live birth Cycle 28 31 0.9 (0.8 to 1.0) 24 31 0.7 (0.6 to 0.9)
Maheshwari et al. (2009a) C-S IVF 1756 Live birth Woman 23 26 0.9 (0.7 to 1.1) 22 25 0.9 (0.6 to 1.2)
Orvieto et al. (2009a) Cohort IVF/ICSI 516 cp Cycle NA NA NA 20 29 0.6 (0.3 to 1.2)
Matalliotakis et al. (2008) Cohort IVF/ICSI 278 Live birth Woman 47c 46c 1.0 (0.6 to 1.7)c NA NA NA
Sneed et al. (2008) Cohort IVF/ICSI 1273 Live birth Woman 21 24 0.8 (0.6 to 1.1) 22 23 0.9 (0.7 to 1.2)
Esinler et al. (2008) Cohort ICSI 775 cp ET 46 45 1.1 (0.8 to 1.4) 48 45 1.2 (0.8 to 1.6)
Martinuzzi et al. (2008) Cohort IVF/ICSI 417 op Woman 45 47 0.9 (0.6 to 1.4) 42 47 0.8 (0.5 to 1.5)
Thum et al. (2007) Cohort IVF/ICSI 8145 Live birth Woman 26d 29d 0.9 (0.8 to 1.0)d 24e 29e 0.8 (0.6 to 1.0)e
Dokras et al. (2006) Cohort IVF/ICSI 1291 Delivery Woman 42 42 1.0 (0.8 to 1.3) 41 42 0.9 (0.7 to 1.2)
Ku et al. (2006) Cohort ICSI 223 cp Woman 11c 26c 0.3 (0.1 to 1.0)c NA NA NA
Dechaud et al. (2006) Cohort IVF/ICSI 789 op Cycle 13 17 0.8 (0.4 to 1.3) 13 16 0.7 (0.3 to 1.8)
Styne-Gross et al. (2005) Cohort IVF donor oocyte 536 op Woman 74 72 1.1 (0.7 to 1.7) 74 73 1.1 (0.6 to 1.9)
Lintsen et al. (2005) Cohort IVF 8105 Live birth Cycle 14 16 0.9 (0.8 to 1.1) NA NA NA
Van Swieten et al. (2005)b Cohort IVF/ICSI 162 cp Woman 33 46 0.6 (0.3 to 1.1) 41 41 1.0 (0.5 to 2.3)
Spandorfer et al. (2004) Cohort IVF/ICSI 828 cp Cycle 56f 56f 1.0 (0.7 to 1.5)f NA NA NA
Fedorcsak et al. (2004) Cohort IVF/ICSI 2660 Live birth Woman 19 22 0.9 (0.7 to 1.1) 18 21 0.8 (0.6 to 1.1)
Loveland et al. (2001) Cohort IVF 139 op Cycle 25 51 0.3 (0.2 to 0.6) NA NA NA
Salha et al. (2001)b CC IVF 100 cp Woman 26d 38d 0.6 (0.2 to 1.3)d NA NA NA
Wang et al. (2000) Cohort IVF/ICSI 3586 Fecundity Cycle 40 47 0.8 (0.7 to 0.9) 37 46 0.7 (0.6 to 0.9)
Wittemer et al. (2000) Cohort IVF/ICSI 325 Delivery Cycle 14 17 0.8 (0.4 to 1.7) NA NA NA
Lashen et al. (1999)b CC IVF 228 cp Woman 24g 20g 1.2 (0.6 to 2.3)g NA NA NA
C-S, cross-sectional; CC, case–control; cp, clinical pregnancy; op, ongoing pregnancy; ET, embryo transfer; NA, not available.
aComparisons were as stated except where indicated cBMI . 24, dBMI . 26, eBMI . 31, fBMI . 27, gBMI . 28 versus BMI 20–25.
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In the debate whether overweight or obese women should be
denied access to ART, it is of interest to compare the effect of BMI
with that of female age on ART outcome, as this is a well-accepted
criterion to deny or allow ART (Templeton et al., 1996). In view of
the decreasing success rates of ART in older women, most countries
have an upper limit for age with respect to access to ART pro-
grammes. In the Netherlands, national guidelines recommend not
offering ART to women older than 41 years because of poor preg-
nancy chances; but in clinical practice, this threshold has moved to
an age of 43.
Figure 7 shows live birth rates following IVF in relation to female age
for women with a BMI of ,25 and .25 kg/m2, which decrease from
26% for younger women to 10% for women aged 40 (Maheshwari
et al., 2009b). When we consider an effect of overweight and
obesity as pooled OR 0.9, the profound effect of age is much stronger
when compared with the moderate effect of overweight on the live
birth rate following IVF. This combined OR 0.9 should be viewed in
the light of the earlier mentioned remarks on the level of evidence
of the included studies.
Although high BMI is associated with obstetric and perinatal compli-
cations, the BMI thresholds now applied in some countries are not jus-
tiﬁed by empirical evidence. Since weight loss programmes have
shown limited success, thus indicating how difﬁcult it is to lose
weight, certainly in older patients, the gain in outcome variables
must be balanced against the detrimental effect of older age (Sneed
et al., 2008). Indeed, to delay attempts to conceive to the age of 40
is probably more detrimental and perhaps more changeable than
the decision to gain weight.
Figure 6 Live birth rate for overweight and normal weight women.
............................... ...............................
.............................................................................................................................................................................................
Table III Incidence of positive outcomes after ART in overweight and obesea compared with normal weight women with
PCOSb
Study n Per Outcome Incidence (%) OR (95% CI) Incidence (%) OR (95% CI)
BMI > 25 BMI < 25 BMI > 30 BMI < 30
Ozgun et al. (2011)c 44 Woman Live birth NA NA NA 22 46 0.3 (0.1 to 1.3)
Orvieto et al. (2009b) 100 Cycle cp 16 29 0.5 (0.2 to 1.2) NA NA NA
McCormick et al. (2008) 17 Cycle Live birth NA NA NA 46d 83d 0.2 (0.01 to 1.9)d
Kjotrod et al. (2004)c 73 Woman Live birth NA NA NA 38e 39e 0.9 (0.4 to 2.4)e
NA, not available; cp, clinical pregnancy.
aComparisons as stated except where indicated dBMI .30 versus BMI 18.5–24.9, eBMI . 28.
bDeﬁned by Rotterdam criteria.
cProspective study others are retrospective.
Figure 7 Live birth rates following IVF for overweight and normal
weight women in different age groups.
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In the Netherlands, at present, a multicentre randomized controlled
trial is in process which compares lifestyle intervention prior to con-
ventional fertility care (including ART) with direct conventional fertility
care in women with a BMI of ≥29 kg/m2 (Mutsaerts et al., 2010). If
this study shows better results in the treatment group, this would
provide scientiﬁc evidence for recommending lifestyle intervention
before fertility treatment is started.
Apart from the slightly negative effect of BMI ≥ 25 kg/m2 on ART
outcome, there is a substantial risk of pregnancy complications in
overweight and obese women, such as hypertension, gestational dia-
betes, macrosomia and an increased risk of Caesarean section and
perinatal death (Garbaciak et al., 1985; Edwards et al., 1996; Weiss
et al., 2004). Moreover, the general health risk in terms of increased
prevalence of, for example, cardiovascular disease and type 2 diabetes
of overweight is well described (Visscher and Seidell, 2001). In our
opinion, overweight women should be informed about these overall
health risks, obstetric risks and slightly lower success rates of ART
when seeking fertility care.
In conclusion, there is a lack of studies reporting on complications
following ART. In the published literature, we did not ﬁnd more com-
plications in subfertile overweight and obese women when compared
with subfertile normal weight women. We found slightly lower success
rates in these overweight women following ART. Therefore, we feel
there is no evidence for excluding women above a certain BMI thresh-
old from ART but counselling on the increased obstetrical risks is man-
datory. Furthermore, following the recommendations of the SIG Safety
and Quality of the ESHRE, an international complication registration
system for ART should be implemented to increase safety of
women undergoing ART.
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